期刊文献+

利用杆状病毒表达载体系统表达重组乙型肝炎病毒核心蛋白 被引量:2

Expression of Recombinant HBcAg in Baculovirus Expression Vector System
暂未订购
导出
摘要 目的利用杆状病毒表达载体系统制备重组乙型肝炎病毒核心蛋白。方法构建含有HBV C基因的杆状病毒转移载体pFastBac Dual-HBV core,转化大肠埃希菌DH10Bac进行转座,提取重组Bacmid DNA转染昆虫细胞Sf9,获得含有HBV C基因的重组杆状病毒。用重组杆状病毒感染Sf9细胞进行乙型肝炎病毒核心蛋白表达,然后通过SDS-PAGE电泳和Western blot分析表达情况。结果成功构建了含HBV C基因的重组杆状病毒,而且在昆虫细胞Sf9中表达了乙型肝炎病毒核心蛋白。结论利用Bac to Bac杆状病毒表达系统,成功地表达了乙型肝炎病毒核心蛋白,为进一步研究奠定了基础。 Objective To produce recombinant HBcAg in insect cells by Baculovirus expression vector system. Methods HBV core gene was amplified by PCR and cloned into pFastBac Dual vector to construct the recombinant plasmid pFastBac Dual-HBV core, using pMD18-T Simple Vector as a mediator. Then the recombinant plasmid pFastBae Dual-HBV core was transformed into DH10Bac competent cells for transposition, after which the recombinant Bacmid DNA was isolated and transfected into Sf9 insect cells by lipofectamine. Three days later, recombinant baculovi.ruses were harvested to infect Sf9 cells and the expression levels were detected by SDS-PAGE and Western blotting after infection. Results The recombinant baculovirus containing HBV core gene was constructed successfully and HBeAg was expressed in insect cells at a high level. Conclusion The recombinant HBcAg was successfully expressed in insect cells with Bac to Bac expression system, which lays the foundation for further research.
出处 《华中科技大学学报(医学版)》 CAS CSCD 北大核心 2007年第6期787-790,共4页 Acta Medicinae Universitatis Scientiae et Technologiae Huazhong
基金 国家自然科学基金资助项目(No.30330680)
关键词 乙型肝炎病毒核心蛋白 杆状病毒表达载体系统 昆虫细胞 HBcAg Baculovirus expression vector system insect cell
  • 相关文献

参考文献9

  • 1LEVINE S, HERNANDEZ D, YAMANAKA G, et al, Efficacies of entecavir against lamivudine-resistant hepatitis B virus replication and recombinant polymerase in vitro [J]. Antimicrob Agents Chemother, 2002, 46(8): 2525-2532.
  • 2李朝霞,梁敏坚,李林,胡波,朱振宇.乙型肝炎病毒C基因在毕赤酵母中的表达[J].中国病理生理杂志,2004,20(12):2320-2324. 被引量:3
  • 3ROS SINCK M J. Expression of hepatitis B rival core region in mammalian cells[J]. Mol Cell Biol, 1986, 6(5): 1393-1400.
  • 4朱江,吴祥甫.昆虫杆状病毒表达系统研究进展及其应用展望[J].蚕业科学,2003,29(2):114-119. 被引量:17
  • 5SEIFER M, HAMATAKE R, BIFANO M, et al. Generation of replication-competent hepatitis B virus nucleocapsids in insect cells[J]. J Virol, 1998, 72(4): 2765-2776.
  • 6HATTON T, ZHOU S, STANDRING D N. RNA-and DNA- binding activities in hepatitis B virus capsid protein: a model for their roles in viral replication[J]. J Virol, 1992, 66 (9) : 5232-5241.
  • 7WATELET B, QUIBRIAC M, ROLLAND D, et al. Erratum to "charaterization and diagnostic potential of hepatitis B virus nucleocapsid expressed in E. coli and P pastoris"[J]. J Virol Methods, 2002, 99(1/2): 99-114.
  • 8WENTWORTH P A,CELIS E,CRIMI C, et al. In vitro induction of primary antigen specific from human peripheral blood mononuclear cells stimulated with smthetic peptides[J]. Med Immunol,1995,32(9) : 603-612.
  • 9石统东,边疆,万瑛,贾正才,周伟,邹丽云,吴玉章.乙型肝炎病毒HBcAg免疫优势CTL表位多肽在HBV转基因小鼠体内的免疫学功能研究[J].免疫学杂志,2003,19(3):186-189. 被引量:8

二级参考文献39

  • 1木村滋.昆虫生物工厂(M)[M].日本:工业调查会,2000.124-127.
  • 2Rotzschke O, Falk K, Deres K, et al. Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells[J] .Nature, 1990,348(6 298) :252 - 254.
  • 3Klenerman P, Zinkernagel RM. Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes[J] :Nature, 1998, 394(6692) :482 - 485.
  • 4Sette AD, Oseroff C, Sidney J, et al. Overcoming T cell tolerance to the hepatitis B vires surface antigen in hepatitis B virus-transgenic mice[J]. J Immunol,2001,166(2) : 1389 -1379.
  • 5Sijts AJ, Ruppert T, Rehermarm B, et al. Efficient generation of a hepatitis B virus cytotoxic T lymphocyte epitope requires the structural features of immunoproteasomes [ J ].J Exp Med, 2000,191(3):503-514.
  • 6Chaiken IM, Williams WV. Identifying structure-function relationships in four-helix bundle cytokines: towards de novo mimetics design [ J ]. Trends Biotechnol, 1996, 14 (10) :369 - 375.
  • 7Scheibenbogen C, Lee KH, Stevanovic S, et al. Analysis of the T cell response to tumor and viral peptide antigens by an IFNγ-ELISPOT assay[J]. Int J Cancer, 1997,71 (6) :932 -936.
  • 8Bocher WO, Dekel B, Schwerin W, et al. Induction of strong hepatitis B virus (HBV) specific T helper cell and cytotoxic T lymphocyte responses by therapeutic vaccination in the trimera mouse model of chronic HBV infection [ J ]. Eur J Immunol,2001,31(7): 2071-2079.
  • 9Lackow V A. Protein production and processing from baculovirus expression vectors. In "Baculovirus expression systems and biopesticides"(M). New York: Wiley-Liss, Inc, 1995.51-90.
  • 10Merrington C L. Baculovirus expression systems. In "Protein Expression:a practical approach"(M).New York:Oxford University press Inc, 1999.101-127.

共引文献24

同被引文献51

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部